Planned re-placement of shares to increase free float
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014
Trostberg, May 19, 2021 – The shareholders LIVIA Corporate Development SE and HDI Vier CE GmbH informed AlzChem Group AG that they intend to sell approximately 1.5 million shares (approximately 15% of the share capital) to institutional investors via a private placement. Discussions to this effect are already at an advanced stage. With this placement, the selling shareholders are pursuing the goal of increasing the free float and thus the liquidity of AlzChem Group AG shares. They continue to be convinced of the company’s strong development and will remain associated with it in the long term and, if necessary, enter into corresponding lock-up obligations.
AlzChem Group AG expressly welcomes the increase in the free float. This is in line with a long-held wish of the company.
AlzChem is a globally active specialty chemicals company that is one of the market leaders in its fields of activity, also in the international segment. With its broad product range, AlzChem benefits in a special way from the four very different global megatrends of energy efficiency, sustainability, healthy aging and population growth, insofar as efficiency in food production can be decisively improved. Here, AlzChem products offer attractive solutions in a wide range of different applications.
The company sees interesting growth prospects for itself in particular in the areas of human and animal nutrition, pharmaceuticals, agriculture, fine chemicals, metallurgy and renewable energies. The company’s broad product range includes dietary supplements, plant growth regulators and precursors for corona tests.
AlzChem employs around 1,630 people at four production sites in Germany and Sweden, and at two sales companies in the USA and China. In 2020, AlzChem generated consolidated sales of around EUR 379 million and EBITDA of around EUR 53.8 million.